← Back to home

PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BUT RESECTABLE CLEAR CELL RENAL CELL CARCINOMA

Clinical trials for PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BUT RESECTABLE CLEAR CELL RENAL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BUT RESECTABLE CLEAR CELL RENAL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BUT RESECTABLE CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Drug cocktail aims to shrink kidney tumors before surgery and prevent return

Disease control Not yet recruiting

This phase 2 trial is testing whether a combination of two drugs—zanzalintinib (a pill taken daily) and pembrolizumab (given by IV every three weeks)—can shrink advanced kidney tumors before surgery and help prevent the cancer from coming back afterward. The study enrolls people …

Matched conditions: PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BUT RESECTABLE CLEAR CELL RENAL CELL CARCINOMA

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC

PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BUT RESECTABLE CLEAR CELL RENAL CELL CARCINOMA

Get alerted when new PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BUT RESECTABLE CLEAR CELL RENAL CELL CARCINOMA trials appear

Drug cocktail aims to shrink kidney tumors before surgery and prevent return